ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

QTTB vs AMRN // EV/EBITDA & P/E VALUATION

Q32 Bio Inc. (NASDAQ) VS. Amarin Corporation plc (NASDAQ) • 15-METRIC TALLY: QTTB 6 — AMRN 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QTTB VS. AMRN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC QTTB AMRN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 56.60% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 85.00% -12.20% +97.20 QTTB /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 12.8x — — TIE /valuation <GO>
Free Cash Flow Yield -12.70% 2.56% -15.26 AMRN /fcf-yield <GO>
Operating Margin 31.50% -23.50% +55.00 QTTB /operating-margins <GO>
Net Profit Margin 55.50% -18.20% +73.70 QTTB /net-margins <GO>
Revenue Growth (YoY) — -6.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.99 0.20 +5.79 QTTB /balance-sheet <GO>
Piotroski F-Score Quality 4/9 6/9 -2.00 AMRN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.1 46.6 +1.47 QTTB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 8.3x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $264.1M $262.8M $1.3M QTTB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR QTTB REV AMRN REV QTTB GROSS % AMRN GROSS % QTTB FCF AMRN FCF
FY 2025 $53.7M $213.6M — 56.6% -$33.5M $6.7M
FY 2024 $0 $228.6M — 35.6% -$67.8M -$31.0M
FY 2023 $1.2M $306.9M — — -$18.7M $6.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QTTB // BETA —
AMRN // BETA —